ID   K562-L
AC   CVCL_9122
DR   Wikidata; Q54899393
RX   PubMed=7689892;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=7689892; DOI=10.1248/bpb.16.548;
RA   Sasaki D., Kosunago S., Hirano J., Matsuda K., Hata Y., Komiyama Y.,
RA   Mikami T., Matsumoto T., Suzuki M.;
RT   "Cloning and characterization of K562 cells on hemoglobin synthetic
RT   activity.";
RL   Biol. Pharm. Bull. 16:548-551(1993).
//